Azimuth Capital Investment Management LLC Vertex Pharmaceuticals Inc Transaction History
Azimuth Capital Investment Management LLC
- $2.41 Billion
- Q1 2025
A detailed history of Azimuth Capital Investment Management LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Azimuth Capital Investment Management LLC holds 21,243 shares of VRTX stock, worth $9.26 Million. This represents 0.43% of its overall portfolio holdings.
Number of Shares
21,243
Previous 22,141
4.06%
Holding current value
$9.26 Million
Previous $8.92 Million
15.51%
% of portfolio
0.43%
Previous 0.36%
Shares
12 transactions
Others Institutions Holding VRTX
# of Institutions
1,830Shares Held
233MCall Options Held
1.38MPut Options Held
1.08M-
Capital World Investors Los Angeles, CA28.5MShares$12.4 Billion2.34% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.5MShares$10.2 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.29 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA14.5MShares$6.34 Billion1.6% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.14 Billion0.24% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $112B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...